Myelosuppressive effects of 111indium-pentetreotide therapy for somatostatin receptor expressing neoplasms.

被引：0
|
作者：
Anthony, LB
Woltering, EA
Espenan, GD
Cronin, MD
Maloney, TJ
McCarthy, KE
机构：
[1] Louisiana State Univ, Med Ctr, New Orleans, LA USA
[2] Isotex Inc, Friendswood, TX USA
来源：
BLOOD | 1998年 / 92卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3999
引用
收藏
页码：233B / 233B
页数：1
相关论文
共 50 条
  • [1] 111Indium-Pentetreotide Scintigraphy In Pulmonary Fibrosis
    Lebtahi, R.
    Crestani, B.
    Marchand-Adam, S.
    Moreau, S.
    Bleichner-Perez, S.
    Debray, M.
    Aubier, M.
    Merlet, P.
    Reubi, J.
    Le Guludec, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S215 - S215
  • [2] Utility of 111Indium-pentetreotide Scintigraphy in Patients with Neuroendocrine Tumors
    Shaverdian, Narek
    Pinchot, Scott N.
    Zarebczan, Barbara
    Gillis, Holly C.
    Schiro, Adam
    Chen, Herbert
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 (02) : 640 - 645
  • [3] Indium-111 pentetreatide therapy in somatostatin receptor expressing neoplasms: Results from clinical practice
    Le, L
    Linares, L
    Andrews, S
    Anthony, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 380S - 380S
  • [4] Utility of 111Indium-pentetreotide Scintigraphy in Patients with Neuroendocrine Tumors
    Narek Shaverdian
    Scott N. Pinchot
    Barbara Zarebczan
    Holly C. Gillis
    Adam Schiro
    Herbert Chen
    Annals of Surgical Oncology, 2013, 20 : 640 - 645
  • [5] Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide
    Schillaci, O
    Annibale, B
    Scopinaro, F
    DelleFave, G
    Colella, AC
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (06) : 886 - 887
  • [6] 111Indium-pentetreotide pituitary scintigraphy and hormonal responses to octreotide in acromegalic patients
    Pietro Legovini
    E. De Menis
    D. Billeci
    B. Conti
    P. Zoli
    N. Conte
    Journal of Endocrinological Investigation, 1997, 20 : 424 - 428
  • [7] Measurement of radioactivity in breast milk following maternal administration of 111Indium-Pentetreotide
    Bidder, R.
    Humphreys, C.
    Evans, S.
    Smakovs, A.
    Ali, P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S345 - S345
  • [8] Somatostatin receptor scintigraphy with 111-indium pentetreotide for staging of Hodgkin's lymphomas.
    vandenAnkerLugtenburg, PJ
    Lowenberg, B
    Lamberts, SWJ
    Oei, HY
    Valkema, R
    Krenning, EP
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 379 - 379
  • [9] Role of somatostatin receptor scintigraphy with indium 111-pentetreotide in gastroenteropancreatic endocrine tumours.
    Lebtahi, R
    Cadiot, G
    Mignon, M
    LeGuludec, D
    MEDECINE NUCLEAIRE, 1996, 20 (4-5): : 304 - 308
  • [10] BIODISTRIBUTION OF IN-111 PENTETREOTIDE AND DOSIMETRIC CONSIDERATIONS WITH RESPECT TO SOMATOSTATIN RECEPTOR EXPRESSING TUMOR BURDEN
    ADRIAN, HJ
    DORR, U
    BACH, D
    BIHL, H
    HORMONE AND METABOLIC RESEARCH, 1993, 27 : 18 - 23
12345